130 related articles for article (PubMed ID: 29970523)
21. Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.
Paterna A; Kincses A; Spengler G; Mulhovo S; Molnár J; Ferreira MU
Eur J Med Chem; 2017 Mar; 128():247-257. PubMed ID: 28189906
[TBL] [Abstract][Full Text] [Related]
22. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
[TBL] [Abstract][Full Text] [Related]
23. Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function.
Tao LY; Liang YJ; Wang F; Chen LM; Yan YY; Dai CL; Fu LW
Cancer Chemother Pharmacol; 2009 Oct; 64(5):961-9. PubMed ID: 19255759
[TBL] [Abstract][Full Text] [Related]
24. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
[TBL] [Abstract][Full Text] [Related]
25. Fluorinated β-Diketo Phosphorus Ylides Are Novel Inhibitors of the ABCB1 Efflux Pump of Cancer Cells.
Spengler G; Ocsovszki I; Tönki ÁS; Saijo R; Watanabe G; Kawase M; Molnár J
Anticancer Res; 2015 Nov; 35(11):5915-9. PubMed ID: 26504015
[TBL] [Abstract][Full Text] [Related]
26. Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1).
Schmitt SM; Stefan K; Wiese M
J Med Chem; 2016 Apr; 59(7):3018-33. PubMed ID: 26943020
[TBL] [Abstract][Full Text] [Related]
27. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
28. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
[TBL] [Abstract][Full Text] [Related]
29. Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.
Csonka Á; Hamdoun S; Spengler G; Martins A; Vincze I; Efferth T; Molnár J
Anticancer Res; 2015 Apr; 35(4):2105-12. PubMed ID: 25862866
[TBL] [Abstract][Full Text] [Related]
30. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents.
Chen CY; Liu NY; Lin HC; Lee CY; Hung CC; Chang CS
Eur J Med Chem; 2016 Aug; 118():219-29. PubMed ID: 27131064
[TBL] [Abstract][Full Text] [Related]
32. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
[TBL] [Abstract][Full Text] [Related]
33. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
34. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
35. Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter.
Martins A; Tóth N; Ványolós A; Béni Z; Zupkó I; Molnár J; Báthori M; Hunyadi A
J Med Chem; 2012 Jun; 55(11):5034-43. PubMed ID: 22578055
[TBL] [Abstract][Full Text] [Related]
36. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance.
Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P
Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650
[TBL] [Abstract][Full Text] [Related]
37. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
[TBL] [Abstract][Full Text] [Related]
38. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
[TBL] [Abstract][Full Text] [Related]
39. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
[TBL] [Abstract][Full Text] [Related]
40. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
